Medicare Enrolled
Dr. Brian Friel, MD
Student in an Organized Health Care Education/Training Program · Philadelphia, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Friel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Friel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Friel
Dr. Brian Friel is a student in an organized health care education/training program specialist in Philadelphia, PA, with 9 years of NPI registration. Based on federal Medicare data, Dr. Friel performed 3,841 Medicare services across 1,847 unique beneficiaries.
Between the years covered by Open Payments, Dr. Friel received a total of $4,476 from 35 pharmaceutical and/or device companies across 154 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Friel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years in practice
▲ Top 3% volume in PA
$4,476 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,841
Medicare services
Top 3% in PA for student in an organized health care education/training program
1,847
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~427 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 1,300 | $2 | $6 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
655 | $3 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
473 | $101 | $305 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
247 | $65 | $117 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
230 | $68 | $211 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
219 | $9 | $70 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
180 | $129 | $358 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
64 | $63 | $600 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
43 | $104 | $215 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
43 | $52 | $85 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
36 | $8 | $12 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 33 | $127 | $800 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
32 | $50 | $149 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
32 | $142 | $316 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
28 | $119 | $507 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
27 | $71 | $222 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
26 | $26 | $250 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
26 | $47 | $84 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
25 | $104 | $455 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
19 | $120 | $1,053 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
18 | $337 | $785 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
15 | $74 | $460 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
13 | $28 | $100 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $148 | $472 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
11 | $292 | $692 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
11 | $27 | $437 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
11 | $163 | $366 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
11 | $41 | $102 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.1% high complexity
7.7% medium
90.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,476
Total received (2021-2024)
Avg $1,119/year across 4 years
Top 8% in PA for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
154
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,476 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,856
2023
$1,467
2022
$1,134
2021
$18
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Axonics, Inc.
$288
Dendreon Pharmaceuticals LLC
$216
ABBVIE INC.
$193
Janssen Biotech, Inc.
$191
Astellas Pharma US Inc
$161
PROCEPT BioRobotics Corporation
$129
Bayer Healthcare Pharmaceuticals Inc.
$86
Tolmar, Inc.
$83
Medtronic, Inc.
$81
UROGEN PHARMA, INC.
$50
Telix Pharmaceuticals
$46
Sumitomo Pharma America, Inc.
$44
Merck Sharp & Dohme LLC
$39
BIOPROTECT MEDICAL, INC.
$36
Ferring Pharmaceuticals Inc.
$35
Novartis Pharmaceuticals Corporation
$33
180 Medical, Inc.
$31
PROGENICS PHARMACEUTICALS, INC.
$26
Myriad Genetic Laboratories, Inc.
$21
AstraZeneca Pharmaceuticals LP
$20
IMMUNITYBIO, INC.
$17
PFIZER INC.
$16
Mission Pharmacal Company
$16
Top 3 companies account for 37.5% of 2024 payments
All-time payments by company (2021-2024) ›
Medtronic, Inc.
$819
Axonics, Inc.
$634
Astellas Pharma US Inc
$463
Janssen Biotech, Inc.
$369
ABBVIE INC.
$327
Dendreon Pharmaceuticals LLC
$259
Teleflex LLC
$203
Tolmar, Inc.
$138
PROCEPT BioRobotics Corporation
$129
Bayer Healthcare Pharmaceuticals Inc.
$118
Boston Scientific Corporation
$116
PFIZER INC.
$87
Merck Sharp & Dohme LLC
$80
Progenics Pharmaceuticals, Inc.
$74
UroGen Pharma, Inc.
$65
Myriad Genetic Laboratories, Inc.
$63
UROGEN PHARMA, INC.
$50
Telix Pharmaceuticals
$46
Sumitomo Pharma America, Inc.
$44
BIOPROTECT MEDICAL, INC.
$36
Ferring Pharmaceuticals Inc.
$35
Novartis Pharmaceuticals Corporation
$33
180 Medical, Inc.
$31
UROVANT SCIENCES INC
$29
Amgen Inc.
$26
PROGENICS PHARMACEUTICALS, INC.
$26
Curium US LLC
$26
Antares Pharma, Inc.
$23
ABC Home Medical Supply, Inc.
$21
AstraZeneca Pharmaceuticals LP
$20
Endo Pharmaceuticals Inc.
$20
BOSTON SCIENTIFIC CORPORATION
$18
IMMUNITYBIO, INC.
$17
Smith+Nephew, Inc.
$16
Mission Pharmacal Company
$16
Top 3 companies account for 42.8% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS 700 CXR RTE KIT · AMS 700 CXR RTE Kit · ANKTIVA · AQUABEAM SYSTEM · Axonics · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · Bulkamid · ELIGARD · ERLEADA · GEMTESA · GRAFIX PL · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · LYNPARZA · Myrbetriq · Nubeqa · ORGOVYX · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Rezum Generator · URIBEL TABS · UROLIFT · UroLift System · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for student in an organized health care education/training program in PA.
Geographic Context
Student in an organized health care education/training programs within 10 mi
7,691
Per 100K population
486.0
County median income
$60,698
Nearest hospital
PHILADELPHIA VA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Friel is a clinical cardiology specialist, with above-average Medicare volume (top 3% in PA), with low-engagement industry engagement in the top 8% of PA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Friel experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Friel performed 1,300 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Friel receive payments from pharmaceutical companies?
Yes. Dr. Friel received a total of $4,476 from 35 companies across 154 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Friel's costs compare to other student in an organized health care education/training programs in Philadelphia?
Dr. Friel's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Friel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Philadelphia
Browse student in an organized health care education/training programs in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in PA
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in PA
Which PA student in an organized health care education/training programs receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology